Role of antioxidant enzymes in brain tumours

Clin Chim Acta. 2000 Jun;296(1-2):203-12. doi: 10.1016/s0009-8981(00)00219-9.

Abstract

Erythrocyte antioxidant enzymes were analysed in 100 patients with intracranial neoplasm and in 47 controls. There was a significant decrease in RBC glutathione reductase (GRx) and superoxide dismutase (SOD) activity in most types of brain tumor cases. Patients with acoustic neurinoma showed a significant reduction in selenium-dependent glutathione peroxidase (Se-GPx) activity. A decrease in catalase (CT) activity was seen in most of the brain tumor patients but remained statistically insignificant when compared to controls. A significant increase in plasma ceruloplasmin concentration was observed in patients with glioma. These enzymes were also studied in 27 post-treatment cases. GRx activity returned to normal levels in these patients. RBC SOD and plasma ceruloplasmin levels showed a tendency to return to normal. Hence, a marked decrease in the antioxidant enzymes may have a role in the genesis of considerable oxidative stress in patients with brain tumors.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antioxidants / metabolism*
  • Brain Neoplasms / enzymology*
  • Catalase / blood
  • Ceruloplasmin / analysis
  • Erythrocytes / enzymology
  • Female
  • Glioma / enzymology
  • Glutathione Peroxidase / blood
  • Glutathione Reductase / blood
  • Humans
  • Male
  • Meningioma / enzymology
  • Middle Aged
  • Neuroma, Acoustic / enzymology
  • Selenium / pharmacology
  • Superoxide Dismutase / blood

Substances

  • Antioxidants
  • Catalase
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Ceruloplasmin
  • Glutathione Reductase
  • Selenium